For a decade, we’ve treated cytosolic mitochondrial DNA (mtDNA) as a catastrophic failure—a leak we need to plug. Current trends favor targeting the cGAS-STING pathway to muffle the "noise" of inflammaging. But we're ignoring a messy possibility: what if that noise is actually a high-fidelity triage signal we’re about to lobotomize?

Mitochondria are the primary sensors of metabolic health. When they dump mtDNA into the cytoplasm, they aren’t just breaking. They’re casting a vote. By hitting the STING button, the cell signals its own obsolescence to the immune system. It’s an act of biological honesty.

If we develop STING inhibitors to "cure" aging, we risk creating a population of informational ghosts. These cells are functionally compromised and potentially oncogenic, but we’ve chemically silenced them so they can’t scream for the immune system to delete them. We’re effectively keeping the lights on in a building that’s lost its structural integrity. It’s a trade: acute inflammation for chronic cellular stagnation. Masking the signal doesn't repair the mitochondria; it just stops the tissue from recycling the failure.

I suspect inflammaging isn't the primary driver of decline. It looks more like a desperate, failed attempt at homeostatic clearance that's being throttled by a lack of systemic resources. We shouldn’t be muting the signal. We should be asking why the clearance mechanisms—the macrophages and NK cells—aren't responding to the alarm anymore.

Is anyone else worried that "anti-inflammatory" longevity is actually just a recipe for accelerated proteostatic collapse? We need longitudinal data on STING-inhibited models and collaborators willing to look at the debris of suppressed immunity before we silence the cell’s last will and testament. We’re funded to extend life, not to archive its wreckage.